Hollencrest Capital Management nearly exited UNH in Q2 2026, but much larger institutions piled in. Analysts remain bullish with price targets up to $490. For finance readers, the 13F reveals a rotation in shares rather than a fundamental warning.
Source: Ticker Report · Daily Political
After a turbulent 2025 marked by cyberattack fallout and operational pressures, UnitedHealth Group is regaining its footing. A key management change has reignited confidence, and the company’s stock is now a top contributor to a major growth fund, signaling a broader sector recovery.
UnitedHealth Group has emerged as a top contributor in Janus Henderson’s Forty Fund, which returned 19% in Q2 2026. The stock closed at $414.40 on July 31, and its recovery—catalyzed by a management change—has put it back on institutional investors’ radar.
Source: insidermonkey.com · finance.yahoo.com